The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006
Open accessAbstract
We analyzed hospital records to provide a population-based estimate of zygomycosis incidence and trends over a 10-year period at a national level in France. Data showed an increasing incidence from 0.7/million in 1997 to 1.2/million in 2006 (p<0.001). We compared our data with those from the French Mycosis Study Group, a recently established voluntary network of French mycologists coordinated by the National Reference Center for Mycoses and Antifungals. We documented that incidence of zygomycosis increased, particularly in patients with hematologic malignancies or bone marrow transplants. The role of previous exposure to antifungal drugs lacking activity against zygomycetes could explain this increase but does not appear exclusive. Incidence also increased in the population of patients with diabetes mellitus. We conclude that observed trends reflect a genuine increase of zygomycosis cases in at-risk populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044
Ribes, J. A., Vanover-Sams, C. L., & Baker, D. J. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.2.236 · Cited by 1,711
Novel perspectives on mucormycosis: pathophysiology, presentation, and management
Spellberg, B., Edwards, J., & Ibrahim, A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.556-569.2005 · Cited by 1,537
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
(2006) · PubMed · Cited by 906
Chamilos, G., Lewis, R. E., & Kontoyiannis, D. P. (2008) · Clinical Infectious Diseases · doi:10.1086/590004 · Cited by 826
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Perlroth, J., Choi, B., & Spellberg, B. (2007) · Medical Mycology · doi:10.1080/13693780701218689 · Cited by 738
Kontoyiannis, D. P., Lionakis, M. S., Lewis, R. E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T. J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428780 · Cited by 674
Posaconazole Is Effective as Salvage Therapy in Zygomycosis: A Retrospective Summary of 91 Cases
van Burik, J.-A. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/500212 · Cited by 615
Prabhu, R. M., & Patel, R. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00843.x · Cited by 593
Posaconazole as Salvage Therapy for Zygomycosis
Greenberg, R. N., Mullane, K., van Burik, J.-A. H., Raad, I., Abzug, M. J., Anstead, G., Herbrecht, R., Langston, A., Marr, K. A., Schiller, G., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.126-133.2006 · Cited by 555
Marty, F. M., Cosimi, L. A., & Baden, L. R. (2004) · New England Journal of Medicine · doi:10.1056/nejm200402263500923 · Cited by 426
Breakthrough Fungal Infections in Stem Cell Transplant Recipients Receiving Voriconazole
Imhof, A., Balajee, S. A., Fredricks, D. N., Englund, J. A., & Marr, K. A. (2004) · Clinical Infectious Diseases · doi:10.1086/423274 · Cited by 402
Rees, J. R., Pinner, R. W., Hajjeh, R. A., Brandt, M. E., & Reingold, A. L. (1998) · Clinical Infectious Diseases · doi:10.1093/clinids/27.5.1138 · Cited by 397
The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus
Chakrabarti, A., Das, A., Mandal, J., Shivaprakash, M. R., George, V. K., Tarai, B., Rao, P., Panda, N., Verma, S. C., & Sakhuja, V. (2006) · Medical Mycology · doi:10.1080/13693780500464930 · Cited by 376
Zygomycosis: the re-emerging fungal infection
Chayakulkeeree, M., Ghannoum, M. A., & Perfect, J. R. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0107-1 · Cited by 368
Siwek, G. T., Dodgson, K. J., de Margarida, M.-S., Bartelt, L. A., Kilborn, S. B., Hoth, P. L., Diekema, D. J., & Pfaller, M. A. (2004) · Clinical Infectious Diseases · doi:10.1086/422723 · Cited by 293
Zygomycosis (mucormycosis): emerging clinical importance and new treatments
Greenberg, R. N., Scott, L. J., Vaughn, H. H., & Ribes, J. A. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200412000-00003 · Cited by 258
Singh, N., Aguado, J. M., Bonatti, H., Forrest, G., Gupta, K. L., Safdar, N., John, G. T., Pursell, K. J., Muñoz, P., Patel, R., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605445 · Cited by 233
Self-citationActivity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis
Dannaoui, E., Meis, J. F. G. M., Loebenberg, D., & Verweij, P. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3647-3650.2003 · Cited by 159
Self-citationMucormycosis: an emerging disease?
Bouza, E., Muñóz, P., & Guinea, J. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01604.x · Cited by 151
van Burik, J. H., Hare, R. S., Solomon, H. F., Corrado, M. L., & Kontoyiannis, D. P. (2006) · Clinical Infectious Diseases · Cited by 140
Vigouroux, S., Morin, O., Moreau, P., Mechinaud, F. M., Morineau, N., Mahé, B., Chevallier, P., Guillaume, T., Dubruille, V., Harousseau, J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427752 · Cited by 120
Impact of Zygomycosis on Microbiology Workload: a Survey Study in Spain
Torres-Narbona, M., Guinea, J., Martínez-Alarcón, J., Muñóz, P., Gadea, I., & Bouza, E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02473-06 · Cited by 119
Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis
Spellberg, B. J., Andes, D. R., Perez, M., Anglim, A. M., Bonilla, H. F., Mathisen, G. E., Walsh, T. J., & Ibrahim, A. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00361-09 · Cited by 93
Gallay, A., Vaillant, V., Bouvet, P., Grimont, P. A. D., & Desenclos, J. C. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.2.171 · Cited by 62
Self-citationPrevalence and treatment of diabetes in France: Trends between 2000 and 2005
Kusnik-Joinville, O., Weill, A., Salanave, B., Ricordeau, P., & Allemand, H. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.01.005 · Cited by 61
Chang, D. C., Burwell, L. A., Lyon, G. M., Pappas, P. G., Chiller, T. M., Wannemuehler, K. A., Fridkin, S. K., & Park, B. J. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/524324 · Cited by 51
Tricco, A. C., Pham, B., & Rawson, N. S. B. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.009 · Cited by 51
Blin, N., Morineau, N., Gaillard, F., Morin, O., Milpied, N. J., Harousseau, J., & Moreau, P. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190410001700803 · Cited by 40
Soummer, A., Mathonnet, A., Scatton, O., Massault, P. P., Paugam, A., Lemiale, V., Mira, J. P., Dannaoui, É., Cariou, A., & Lortholary, O. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01611-07 · Cited by 36
Self-citationAcute Encephalitis Hospitalizations, California, 1990–1999: Unrecognized Arboviral Encephalitis?
Trevejo, R. T. (2004) · Emerging infectious diseases · doi:10.3201/eid1008.030698 · Cited by 36
Girmenia, C., Moleti, M. L., Micozzi, A., Iori, A. P., Barberi, W., Foà, R., & Martino, P. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5395-5396.2005 · Cited by 30
Hafdi‐Nejjari, Z., Couris, C. M., Schott, A., et al. (2006) · Revue d Épidémiologie et de Santé Publique · doi:10.1016/s0398-7620(06)76737-2 · Cited by 25
Cited by
Epidemiology and Clinical Manifestations of Mucormycosis
Petrikkos, G., Skiada, A., Lortholary, O., Roilides, E., Walsh, T. J., & Kontoyiannis, D. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir866 · Cited by 1,452
Self-citationGlobal Epidemiology of Mucormycosis
Prakash, H., & Chakrabarti, A. (2019) · Journal of Fungi · doi:10.3390/jof5010026 · Cited by 938
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013
Cornely, O. A., Arikan-Akdagli, S., Dannaoui, E., Groll, A. H., Lagrou, K., Chakrabarti, A., Lanternier, F., Pagano, L., Skiada, A., Akova, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12371 · Cited by 863
Self-citationSkiada, A., Pagano, L., Groll, A., Zimmerli, S., Dupont, B., Lagrou, K., Lass-Florl, C., Bouza, E., Klimko, N., Gaustad, P., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03456.x · Cited by 748
Epidemiology and Diagnosis of Mucormycosis: An Update
Skiada, A., Pavleas, I., & Drogari-Apiranthitou, M. (2020) · Journal of Fungi · doi:10.3390/jof6040265 · Cited by 687
Metadata
- Authors
- Bitar, D., Van Cauteren, D., Lanternier, F., Dannaoui, E., Che, D., Dromer, F., Desenclos, J.-C., & Lortholary, O.
- Venue
- Emerging Infectious Diseases
- Published
- 2009-09
- Volume
- 15
- Issue
- 9
- Pages
- 1395-1401
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2160018834
- Cited by
- 429
- References
- 34
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.